Evidence map›Paper›PMID 38903128›Full record

ArticleAsian journal of pharmaceutical sciences2024

A biomimetic spore nanoplatform for boosting chemodynamic therapy and bacteria-mediated antitumor immunity for synergistic cancer treatment.

Cuixia Zheng, Lingling Sun, Hongjuan Zhao, Mengya Niu, Dandan Zhang, Xinxin Liu, Qingling Song, Weijie Zhong, Baojin Wang, Yun Zhang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Asian journal of pharmaceutical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Cuixia ZhengHuaihe Hospital of Henan University, Translational medicine Center, Kaifeng 475000, China.
Lingling SunWeihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai 264200, China.
Hongjuan ZhaoSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Mengya NiuSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Dandan ZhangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Xinxin LiuSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Qingling SongSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Weijie ZhongHuaihe Hospital of Henan University, Translational medicine Center, Kaifeng 475000, China.
Baojin WangGynecology, the Third Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Yun ZhangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Lei WangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial-based antitumor immunity has become a promising strategy to activate the immune system for fighting cancer. However, the potential application of bacterial therapy is hindered by the presence of instability and susceptibility to infections within bacterial populations. Furthermore, monotherapy is ineffective in completely eliminating complex cancer with multiple contributing factors. In this study, based on our discovery that spore shell (SS) of

Indexed as

Bacteria-mediated antitumor therapyBiomimetic spore shellChemodynamic therapyImmunotherapyTumor microenvironment

Identifiers

PMID38903128
PMCPMC11186965

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.